Literature DB >> 33562292

Malnutrition in Patients with Liver Cirrhosis.

Julia Traub1, Lisa Reiss1, Benard Aliwa2, Vanessa Stadlbauer2.   

Abstract

Liver cirrhosis is an increasing public health threat worldwide. Malnutrition is a serious complication of cirrhosis and is associated with worse outcomes. With this review, we aim to describe the prevalence of malnutrition, pathophysiological mechanisms, diagnostic tools and therapeutic targets to treat malnutrition. Malnutrition is frequently underdiagnosed and occurs-depending on the screening methods used and patient populations studied-in 5-92% of patients. Decreased energy and protein intake, inflammation, malabsorption, altered nutrient metabolism, hypermetabolism, hormonal disturbances and gut microbiome dysbiosis can contribute to malnutrition. The stepwise diagnostic approach includes a rapid prescreen, the use of a specific screening tool, such as the Royal Free Hospital Nutritional Prioritizing Tool and a nutritional assessment by dieticians. General dietary measures-especially the timing of meals-oral nutritional supplements, micronutrient supplementation and the role of amino acids are discussed. In summary malnutrition in cirrhosis is common and needs more attention by health care professionals involved in the care of patients with cirrhosis. Screening and assessment for malnutrition should be carried out regularly in cirrhotic patients, ideally by a multidisciplinary team. Further research is needed to better clarify pathogenic mechanisms such as the role of the gut-liver-axis and to develop targeted therapeutic strategies.

Entities:  

Keywords:  cirrhosis; dysbiosis; gut–liver axis; macronutrients; malnutrition; micronutrients; nutritional assessment; nutritional screening

Year:  2021        PMID: 33562292      PMCID: PMC7915767          DOI: 10.3390/nu13020540

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  205 in total

1.  Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.

Authors:  F J Laso; P Lapeña; J I Madruga; J F San Miguel; A Orfao; M C Iglesias; M Alvarez-Mon
Journal:  Alcohol Clin Exp Res       Date:  1997-10       Impact factor: 3.455

2.  [Changes in serum folic acid and vitamin B12 levels in liver cirrhosis and its clinical significance].

Authors:  Y J Zhou; M Y Liang; X Q Zhang
Journal:  Zhonghua Nei Ke Za Zhi       Date:  1992-10

3.  Studies on the ethanol-induced decrease of fatty acid oxidation in rat and human liver slices.

Authors:  R Blomstrand; L Kager; O Lantto
Journal:  Life Sci       Date:  1973-10-16       Impact factor: 5.037

4.  Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis.

Authors:  Dario Rahelić; Milan Kujundzić; Zeljko Romić; Kristina Brkić; Mladen Petrovecki
Journal:  Coll Antropol       Date:  2006-09

5.  Malabsorption and nutritional abnormalities in patients with liver cirrhosis.

Authors:  A Romiti; M Merli; M Martorano; G Parrilli; F Martino; O Riggio; A Truscelli; L Capocaccia; G Budillon
Journal:  Ital J Gastroenterol       Date:  1990-06

6.  Three month intervention with protein and energy rich supplements improve muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease--a randomized controlled trial.

Authors:  Kristina Norman; Henriette Kirchner; Manuela Freudenreich; Johann Ockenga; Herbert Lochs; Matthias Pirlich
Journal:  Clin Nutr       Date:  2007-10-25       Impact factor: 7.324

7.  Nutritional Status and its Impact on Clinical Outcomes for Patients Admitted to Hospital with Cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Ruamthip Supanun; Amporn Atsawarungruangkit
Journal:  J Med Assoc Thai       Date:  2016-02

Review 8.  Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials.

Authors:  Lise L Gluud; Gitte Dam; Mette Borre; Iñigo Les; Juan Cordoba; Giulio Marchesini; Niels K Aagaard; Niels Risum; Hendrik Vilstrup
Journal:  J Nutr       Date:  2013-06-05       Impact factor: 4.798

9.  Factors related to increased resting energy expenditure in men with liver cirrhosis.

Authors:  César Prieto-Frías; Marian Conchillo; Marina Payeras; Mercedes Iñarrairaegui; Delia Davola; Gema Frühbeck; Javier Salvador; Macarena Rodríguez; José Á Richter; Carmen Mugueta; María J Gil; Ignacio Herrero; Jesús Prieto; Bruno Sangro; Jorge Quiroga
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-02       Impact factor: 2.566

10.  Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.

Authors:  Benedict Kinny-Köster; Michael Bartels; Susen Becker; Markus Scholz; Joachim Thiery; Uta Ceglarek; Thorsten Kaiser
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

View more
  2 in total

1.  Pyogenic spinal infections in patients with chronic liver disease: illustrative case and systematic review.

Authors:  Gaston Camino-Willhuber; Ryan S Beyer; Matthew J Hatter; Austin J Franklin; Nolan J Brown; Sohaib Hashmi; Michael Oh; Nitin Bhatia; Yu-Po Lee
Journal:  J Neurosurg Case Lessons       Date:  2022-07-25

Review 2.  Nutritional assessment in patients with liver cirrhosis.

Authors:  Sara Haj Ali; Awni Abu Sneineh; Reem Hasweh
Journal:  World J Hepatol       Date:  2022-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.